ICD-10-CM Billable Code

C13.1

Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of aryepiglottic fold, marginal zone
  • Malignant neoplasm of aryepiglottic fold NOS
  • Malignant neoplasm of interarytenoid fold, marginal zone
  • Malignant neoplasm of interarytenoid fold NOS

Excludes Type 2

  • malignant neoplasm of aryepiglottic fold or interarytenoid fold, laryngeal aspect (C32.1)

Medical Intelligence & Overview

Malignant neoplasm of the aryepiglottic fold, classified under ICD-10 code C13.1, is a type of throat cancer that originates in a specific part of the larynx called the aryepiglottic fold. This fold is a tissue band running from the sides of the epiglottis to the arytenoid cartilages, playing a vital role in protecting the airway during swallowing. When a cancer develops in this area on the hypopharyngeal side, it can affect breathing, speech, and swallowing. Recognizing and understanding this condition is crucial for timely diagnosis and treatment, which can significantly impact patient outcomes.

Causes & Symptoms

Clinical Causes: Tobacco use, including smoking cigarettes, cigars, or pipe tobacco Frequent or heavy alcohol consumption Prolonged exposure to irritants or environmental toxins Infections with human papillomavirus (HPV), especially high-risk strains Poor oral hygiene and chronic inflammation of the throat A family history of head and neck cancers Older age, as risk increases with age Previous radiation therapy to the head or neck area

Key Symptoms: Persistent sore throat or mouth pain Difficulty swallowing or a feeling of something stuck in the throat Hoarseness or changes in voice quality Lump or mass in the neck or throat Unintended weight loss Chronic cough or sore throat that does not improve Bleeding from the mouth or throat Ear pain or ringing in the ears, due to nerve involvement Shortness of breath or noisy breathing

Diagnostic & Treatment

Diagnosis Path: To determine the presence of a malignant neoplasm in the aryepiglottic fold, doctors typically perform a combination of assessments and tests, including: - Visual examination using specialized scopes (laryngoscopy) - Imaging studies such as CT scans, MRI, or PET scans to visualize the tumor and assess its spread - Biopsy, where a small tissue sample is collected and examined under a microscope to confirm cancerous cells - Endoscopic procedures that allow detailed inspection of the throat and hypopharyngeal area Early diagnosis is vital for improving treatment options and prognosis.

Treatment Protocols: Treatment strategies for malignant neoplasm of the aryepiglottic fold often involve a multidisciplinary approach, tailored to the tumor's size, location, and stage: - Surgery, to remove the tumor or affected tissue, which might include partial or total removal of the larynx (laryngectomy) - Radiation therapy, to target and destroy cancer cells - Chemotherapy, often used in combination with other treatments to address cancer spread or recurrence - Targeted therapies or immunotherapy, in specific cases, especially if there are genetic markers or high-risk features - Supportive care, including speech and swallowing therapy, to aid recovery post-treatment Prognosis depends on various factors, including the size of the tumor, lymph node involvement, and whether the cancer has spread to other regions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C13.1 a billable ICD-10 code?
Yes, C13.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C13.1?
Clinical documentation must specify the nature of Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

aryepiglottic neoplasm aspect malignant hypopharyngeal